
CJC-1295 with DAC
Synthetic GHRH analogue conjugated to Drug Affinity Complex (DAC) for prolonged bioconjugation studies.

Stable 15-amino acid research pentadecapeptide investigated in cytoprotection models.
Laboratory Research Disclaimer: This chemical compound is sold strictly for analytical, in vitro, and laboratory research investigations. Not approved for human or veterinary administration.
Certified analytical research vials in 3 verified packaging specifications. Direct B2B batch allocation available.
| Cat. No | Configuration / Name | Packaging Spec | Purity / QC | Stock Status | Actions |
|---|---|---|---|---|---|
| BPC-157-PENTADECAPEPTIDE | BPC-157 (Body Protection Compound)Current Selection | Lyophilized Powder, Sterile Sealed Vial | ???99.0% (HPLC) | In Stock (-20°C) | |
| CJC-1295-DAC | CJC-1295 with DAC | Lyophilized Powder, Sterile Sealed Vial | ???98.0% (HPLC) | In Stock (-20°C) | |
| IPAMORELIN-STANDARD | Ipamorelin (Selective GH Secretagogue) | Lyophilized Powder, Sterile Sealed Vial | ???98.5% (HPLC) | In Stock (-20°C) |
Pentadecapeptide derived from human gastric juice protein BPC. Thoroughly purified and characterized for cellular regeneration, nitric oxide signaling, and angiogenic mechanism assays.
Reconstitution & Stability Guidance: Lyophilized peptides should be equilibrated to room temperature before reconstitution. Spin vial gently to ensure all powder is at the bottom. Reconstitute using sterile bacteriostatic or deionized water according to your experimental protocol. Reconstituted solutions should be aliquoted to avoid repeated freeze-thaw cycles and maintained at -20°C or below.

Synthetic GHRH analogue conjugated to Drug Affinity Complex (DAC) for prolonged bioconjugation studies.

Selective pentapeptide growth hormone secretagogue receptor (GHSR-1a) agonist.